{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:30:51Z","timestamp":1770751851876,"version":"3.50.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NHMRC NSW, the Australian Centre for Clinical and Research Excellence"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"DOI":"10.1186\/s12874-025-02757-1","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:36:22Z","timestamp":1768574182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PAtient-Centric epilepsy clinical trIal model For Improved health outcomes using Cannabidiol (PACIFIC study)\u2014a methodology for developing patient-centred clinical trials in rare epilepsy syndromes"],"prefix":"10.1186","volume":"26","author":[{"given":"Linda","family":"Truong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tegan","family":"Stettaford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Watt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafiseh","family":"Ghafournia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Anetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyoung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer H.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"6","key":"2757_CR1","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1016\/S2589-7500(23)00052-3","volume":"5","author":"E Vayena","year":"2023","unstructured":"Vayena E, Blasimme A, Sugarman J. Decentralised clinical trials: ethical opportunities and challenges. Lancet Digit Health. 2023;5(6):e390\u20134.","journal-title":"Lancet Digit Health"},{"issue":"6","key":"2757_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1200\/JCO.2010.32.2685","volume":"29","author":"DA Berry","year":"2011","unstructured":"Berry DA. Adaptive clinical trials: the promise and the caution. J Clin Oncol. 2011;29(6):606\u20139.","journal-title":"J Clin Oncol"},{"key":"2757_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4738","volume":"363","author":"JC Crocker","year":"2018","unstructured":"Crocker JC, Ricci-Cabello I, Parker A, Hirst JA, Chant A, Petit-Zeman S, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. BMJ. 2018;363:k4738.","journal-title":"BMJ"},{"issue":"1","key":"2757_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/epi4.12459","volume":"6","author":"T Baumgartner","year":"2021","unstructured":"Baumgartner T, Carre\u00f1o M, Rocamora R, Bisulli F, Boni A, Br\u00e1zdil M, et al. A survey of the European Reference Network EpiCARE on clinical practice for selected rare epilepsies. Epilepsia Open. 2021;6(1):160\u201370.","journal-title":"Epilepsia Open"},{"issue":"2","key":"2757_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1369-7625.2009.00549.x","volume":"13","author":"TA Abma","year":"2010","unstructured":"Abma TA, Broerse JE. Patient participation as dialogue: setting research agendas. Health Expect. 2010;13(2):160\u201373.","journal-title":"Health Expect"},{"issue":"suppl_1","key":"2757_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/intqhc\/mzx125.8","volume":"29","author":"J Varley","year":"2017","unstructured":"Varley J, Power R, Saris J, Fitzsimons M. ISQUA17-2402co-designing patient-centred care using participatory action research [PAR] - the epilepsy partnership in care [EPIC] project. Int J Qual Health Care. 2017;29(suppl_1):8\u20139.","journal-title":"Int J Qual Health Care"},{"key":"2757_CR7","unstructured":"UCB. Building partnerships with rare epilepsy syndrome patient advocates (FINTEPLA experience). 2021."},{"key":"2757_CR8","unstructured":"(ECET)) ECfETECTN. ERN EpiCARE \u2013 patient advocate involvement. . 2024."},{"issue":"1","key":"2757_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13023-025-03750-z","volume":"20","author":"VM Defelippe","year":"2025","unstructured":"Defelippe VM, Brilstra EH, Otte WM, van Thiel GJMW, Cross HJ, O\u2019Callaghan F, et al. Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies. Orphanet J Rare Dis. 2025;20(1):309.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2757_CR10","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/epi4.13038","volume":"9","author":"J Ferreira","year":"2024","unstructured":"Ferreira J, Peixoto R, Lopes L, Beniczky S, Ryvlin P, Conde C, et al. User involvement in the design and development of medical devices in epilepsy: a systematic review. Epilepsia Open. 2024;9(6):2087\u2013100.","journal-title":"Epilepsia Open"},{"issue":"1","key":"2757_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12874-018-0636-1","volume":"18","author":"MC Sendall","year":"2018","unstructured":"Sendall MC, McCosker LK, Brodie A, Hill M, Crane P. Participatory action research, mixed methods, and research teams: learning from philosophically juxtaposed methodologies for optimal research outcomes. BMC Med Res Methodol. 2018;18(1):167.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2757_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40900-024-00573-3","volume":"10","author":"C Benz","year":"2024","unstructured":"Benz C, Scott-Jeffs W, McKercher KA, Welsh M, Norman R, Hendrie D, et al. Community-based participatory-research through co-design: supporting collaboration from all sides of disability. Res Involv Engagem. 2024;10(1):47.","journal-title":"Res Involv Engagem"},{"key":"2757_CR13","unstructured":"Health AIo, Welfare. Epilepsy in Australia. Canberra: AIHW; 2022."},{"issue":"1","key":"2757_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-016-0409-z","volume":"11","author":"C Molster","year":"2016","unstructured":"Molster C, Urwin D, Di Pietro L, Fookes M, Petrie D, van der Laan S, et al. Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet J Rare Dis. 2016;11(1):30.","journal-title":"Orphanet J Rare Dis"},{"issue":"15","key":"2757_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2165\/00019053-200220150-00002","volume":"20","author":"P Berto","year":"2002","unstructured":"Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics. 2002;20(15):1039\u201359.","journal-title":"Pharmacoeconomics"},{"issue":"14","key":"2757_CR16","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2217\/cer-2019-0054","volume":"8","author":"BR Luce","year":"2019","unstructured":"Luce BR, Simeone JC. How different is research done by the Patient-centered Outcomes Research Institute, and what difference does it make? J Comp Eff Res. 2019;8(14):1239\u201351.","journal-title":"J Comp Eff Res"},{"issue":"5","key":"2757_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5694\/mja18.00023","volume":"209","author":"KA Chen","year":"2018","unstructured":"Chen KA, Farrar M, Cardamone M, Gill D, Smith R, Cowell CT, et al. Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience. Med J Aust. 2018;209(5):217\u201321.","journal-title":"Med J Aust"},{"key":"2757_CR18","unstructured":"(CHF) NHaMRCNatCHFoA. Statement on consumer and community involvement in health and medical research. 2016."},{"key":"2757_CR19","unstructured":"DISEASES NSAPFR. National Strategic Action Plan for Rare Diseases. 2022."},{"key":"2757_CR20","unstructured":"Canberra: NHaMRCN. Ethical conduct in research involving humans. . NHMRC. 2018."},{"issue":"3","key":"2757_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3102\/01623737011003255","volume":"11","author":"JC Greene","year":"1989","unstructured":"Greene JC, Caracelli VJ, Graham WF. Toward a conceptual framework for mixed-method evaluation designs. Educ Eval Policy Anal. 1989;11(3):255\u201374.","journal-title":"Educ Eval Policy Anal"},{"issue":"6","key":"2757_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"2757_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40900-017-0062-2","volume":"3","author":"S Staniszewska","year":"2017","unstructured":"Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al. GRIIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research. Res Involv Engagem. 2017;3(1):13.","journal-title":"Res Involv Engagem"},{"issue":"4","key":"2757_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","volume":"11","author":"V Braun","year":"2019","unstructured":"Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11(4):589\u201397.","journal-title":"Qual Res Sport Exerc Health"},{"key":"2757_CR25","unstructured":"(CHF) NHaMRCNatCHFoA. The Statement on consumer and community involvement in health and medical research (The Statement). In: (CHF) NHaMRCNatCHFoA, editor. Australia2016."},{"key":"2757_CR26","unstructured":"NSW HC. Remuneration and reimbursement of health consumers engaged in health services. Health Consumers NSW2023."},{"issue":"13","key":"2757_CR27","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753\u201360.","journal-title":"Qual Health Res"},{"key":"2757_CR28","unstructured":"Statistics ABo. National, state and territory population. In: Statistics ABo, editor. https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population\/latest-release: Australian Bureau of Statistics; 2023."},{"key":"2757_CR29","unstructured":"Health NMo. Bringing Clinical Trials to the Bush \u2013 improving access to innovative healthcare in rural, regional and remote NSW and ACT. NSW Ministry of Health. 2022."},{"issue":"11","key":"2757_CR30","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.socscimed.2004.11.023","volume":"60","author":"JF Caron-Flinterman","year":"2005","unstructured":"Caron-Flinterman JF, Broerse JE, Bunders JF. The experiential knowledge of patients: a new resource for biomedical research? Soc Sci Med. 2005;60(11):2575\u201384.","journal-title":"Soc Sci Med"},{"issue":"1","key":"2757_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.0013-9580.2004.33403.x","volume":"45","author":"A Aldenkamp","year":"2004","unstructured":"Aldenkamp A, Arends J. The relative influence of epileptic EEG discharges, short nonconvulsive seizures, and type of epilepsy on cognitive function. Epilepsia. 2004;45(1):54\u201363.","journal-title":"Epilepsia"},{"key":"2757_CR32","unstructured":"(FDA) UFaDA. Patient Engagement in the Design and Conduct of Medical Device Clinical Studies Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. In: (FDA) UFaDA, editor. 2022."},{"issue":"8","key":"2757_CR33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2\u2013assessing respondent understanding. Value Health. 2011;14(8):978\u201388.","journal-title":"Value Health"},{"issue":"2","key":"2757_CR34","first-page":"129","volume":"37","author":"SD Faulkner","year":"2023","unstructured":"Faulkner SD, Somers F, Boudes M, Nafria B, Robinson P. Using patient perspectives to inform better clinical trial design and conduct: current trends and future directions. Pharmaceut Med. 2023;37(2):129\u201338.","journal-title":"Pharmaceut Med"},{"key":"2757_CR35","unstructured":"Parkins K HA. Forecast: Decentralised Trials to Reach New Heights with 28% Jump. Clinical Trials Arena. . 2022"},{"key":"2757_CR36","doi-asserted-by":"crossref","unstructured":"Treweek S, Pitkethly M, Cook J, Fraser C, Mitchell E, Sullivan F, et al. Strategies to improve recruitment to randomised trials. Cochrane Database Syst Rev. 2018;2(2):Mr000013.","DOI":"10.1002\/14651858.MR000013.pub6"},{"issue":"1","key":"2757_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13023-022-02522-3","volume":"17","author":"AA Dwyer","year":"2022","unstructured":"Dwyer AA, Uveges M, Dockray S, Smith N. Advancing qualitative rare disease research methodology: a comparison of virtual and in-person focus group formats. Orphanet J Rare Dis. 2022;17(1):354.","journal-title":"Orphanet J Rare Dis"},{"key":"2757_CR38","unstructured":"Organization WH. WHO framework for meaningful engagement of people living with noncommunicable diseases, and mental health and neurological conditions. In: Organization WH, editor. 2023."},{"key":"2757_CR39","doi-asserted-by":"publisher","first-page":"S869","DOI":"10.1016\/j.jval.2019.09.2478","volume":"22","author":"R Camp","year":"2019","unstructured":"Camp R, Houyez F. PRO149 patient engagement in research: the EURORDIS patient-led community advisory boards (CABS). Value Health. 2019;22:S869.","journal-title":"Value Health"},{"issue":"1","key":"2757_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12961-020-0528-9","volume":"18","author":"P Slattery","year":"2020","unstructured":"Slattery P, Saeri AK, Bragge P. Research co-design in health: a rapid overview of reviews. Health Res Policy Syst. 2020;18(1):17.","journal-title":"Health Res Policy Syst"},{"issue":"5","key":"2757_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/1369118X.2015.1012532","volume":"18","author":"L Robinson","year":"2015","unstructured":"Robinson L, Cotten SR, Ono H, Quan-Haase A, Mesch G, Chen W, et al. Digital inequalities and why they matter. Inf Commun Soc. 2015;18(5):569\u201382.","journal-title":"Inf Commun Soc"},{"issue":"1","key":"2757_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2288-14-42","volume":"14","author":"B Bonevski","year":"2014","unstructured":"Bonevski B, Randell M, Paul C, Chapman K, Twyman L, Bryant J, et al. Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol. 2014;14(1):42.","journal-title":"BMC Med Res Methodol"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-025-02757-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:21:06Z","timestamp":1770726066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12874-025-02757-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2757"],"URL":"https:\/\/doi.org\/10.1186\/s12874-025-02757-1","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was provided by the Hunter New England Local Health District Human Research Ethics Committee (HREC) in March 2023 (Reference: 2022\/ETH01648). Ethical approval was obtained from the Hunter New England Local Health District Human Research Ethics Committee (HREC) in March 2023 (Reference: 2022\/ETH01648). The study was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants. Participant confidentiality was maintained throughout the study and after data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No identifying individual-level data is published in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}